1. Johnson DE, Svvanson DA Von Eschenbach AC. Tumors of genitourinary tract. İn: Tanagho EA Mc Aninch _IW. ed Smith's general urology. I2th ed. Appleton 8: Lange, Lebanon, 1988; 33.
2. Catron RS, Kumar V, Robbıns SL Pathologic basış of dısease The lower urinary tract. 5 th ed. Philadelphia: W.B Saunders Company. 1994; 991-1005.
3. Nochomovitz I_E. Bladder biopsy interpretation. First Edition. NewYork: Raven Proj 1992; 73 -126.
4. Witjes JA Kiemeny LA Ooester GO, Debruyne FM. Prognostic factors in superficial Bladder cancer. Eur Urol 1992; 21.89-97.
5. Vıctor ER, Mayron RM. The lovver urinary tract. İn:
Stephan S. Sternberg ed. Diagnostic surgical pathoiogy.
New York: Raven Proj, 1994; 1778-85. 6 Rosai J. Ackerman's surgical pathoiogy: Urinary tract. 7th
ed. St. Louis: The C.V. Mosby Company, 1989; 898-917. 7. Crocker J, Boldy DAR, Egan MJ. How should we count
AglMORs: Proposals for astandardızed approach. J Pathol
1989;158:185-8. 8 Peterson RO. Urologic pathoiogy. Urinary bladder.2th ed
Philadelphia: JB Lippincott Company. 1992. 260-395. 9. Simpson JF, Dutt PL, Page DL. Expession of mitosis per
thousand celi and celi density in breast carcinomas. Hum
Pathol 1992. 23 608-1 I.
. Lipponen PK, Eskelinen MJ, Jauhıamen K. Grading of superficial bladder cancer by quantitative mitotic freuquency analysis. J Urol 1993; 149:36-41.
1 1. Hılsenbeck SG, Alired DC. Universıty of Texas Health Science Center at San Antonla. Improved methods of esti-mating mitotic activity in solid tumors. Editorial. Hum Pathol. 38. Van Diest PJ, Baak JAP. Matzecok P. Wisse-Brekelmans BSC Reproducubiiity of mitosis counting in 2469 breast cancer specimens; Results from the muiticen-ter Morphometric marnmary carcinoma project. Hum Pathol 1992; [23): 601-2.
12. Van Diest PJ. Baak JAP, Matzecok P. Wisse-Brekelmans BSC. Reproducubiiity of mitosis counting in 2469 breast cancer specimens: Results from the multicenter Morphometric marnmary carcinoma project. HumPathof 1992; 23: 603-7.
13. Catalona WJ. Bladder cancer. İn: Gillenwater JY, Grayhack JT, Howards SS, Duckets JYV (Editors).Adult and pediatric urology. 2th ed. Mosby-Year book. İne; 1994,1 135-83.
14. Lucien EN, Nabila EM. The renal pelvis, ureter, urinary Bladder and urethra. İn: Silverberg SG, ed. Principles and praetica of surgical pathoiogy. New York: Churthıl! Livingstone, 1990; 1485-1512.
15. Cohen MB, Waldman FM, Carrol PR, Kerschmann R Comparison of five histopathologic methods to assess cel-lular proliferation in transitional celi carcinoma of the uri¬nary bladder. Hum Pathol 1993;24:772-8.
16. Bozlu M, Orhan D, Baltacı S, Yaman O, Elhan AH, Tulunay O, Müftüoglu YZ. The prognostic value of proliferating celi antigen, Kİ-67 and nucleolar organizer region in transi¬tional celi carcinoma of the bladder. Int Urol Nephrol 2002;33(l);59-66.
I 7. Johnson GC, Miller MA, Ramos-Vara JA Comparısion of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index ın distinguishing benign from malignant canine smooth muscle tümör and in separating inflam-matory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J Vet Diagn Invest J 995,7(1); 127-36.
18. Tomobe M, Shimazui T, Uchida K, Akaza H. AgNOR count in resting cells [resting NOR) is a new prognostic marker in invasive bladder tumor. Anal Celi Pathol 2001;22(4); 193-9.
19. Menon MM, Simha M. Celi adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions-usefulness and limitatıons. Indian J Cancer. 1998;35(4J; 142-6.
20. Akpolat I. Barış YS, Yılmaz AF. Bakırtaş M, Saylık A Karagöz F; Kandemir B Cathepsin B, p53 expression and AgNORs in transitional celi carcinoma. Neoplasma 1998; 4 5 (6)3 6 5-8.
21. Skopelitou A, Korkolopoulou P. Papanİcoiaou A. Christodoulou P, Thomas-Tsagli E, Pavlakis K. Comparative assessment of proliferating celi nuclear anti¬gen immonostaining and of nucleolar organizer region staining in transitional celi carcinomas of the urinary blad¬der. Correiation with other conventional prognostic pathologic parameters. Eur Urol 1992;22(3);235-40.
22. Zambelli S, Zanin A Gaglio A Zai G, Bosco E, Andrion A Magnani C. Ki-67 scores and AgNOR counts in transition¬al celi carcinoma of the bladder: apparent lack of prog¬nostic value. Arch Ital Urol Androl I993;65(6];665-70.
23. Koyuncuoglu M, Kargı A Cingöz S. Kırkalı Z. Investigation of p53, c-erbB-2, PCNA immunoreactivity. DNA content, AgNOR and apoptosis in bladder carcinoma as prognos¬tic parameters. Cancer Lett. 1998; 24; 126(2); 143-8
24. Crocker J, Boldy DAR, Egan MJ. How should we count AgNORs Proposals for astandardızed approach. J Pathol 1989;158:185-8.
25. Heney NM, Ahrned S, F MJ. Frable W, Corder MP, Haferman MD. Superficial bladder cancer: Progression and recurrens. 3 Urol 1983; 130: 1083-6.
26. Griffiths AP, Butler CW, Roberts P. Sılver stained struetures (AgNORs). Their dependence on tissue fixatıon and abss of prognostic relevanc in reetai adenocarcinoma. J. Pathol 1989;159:121-7.
27 Ruschoff J. Zimmermann R, Ulshofer B. Thomas C. Silver-stained nucleolar organizer proteins in urethelial bladder lesions. Path Res Pract 1992;( 188):593-8.
28. Korneyev A Mamaev NfM, Kozlov W, Rybakova, MG, al-Shukri SH. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional celi bladder tumours. Mol Pathol 2000; 54(3):200.
29. Skopelitou A. Korkolopoulou P, Papanİcoiaou A. Comparative assessmentof proliferating celi nuclear anti¬gen immunostaining and of nucleolar organizer region staining in transitional celi carcinomas of the urinary bladder. Eur Urol 1992; 22: 235-40.
30. Martin H, Hufnagl P, Wenzelides K, Beıl M. AgNORs in celi of urothelial carcinoma of the bladder. A quantıtative study using automatic microscopic image analysis Zentralbl Pathol. 1991; 137(6];505-9.
31. Simpson JF. Dutt PL and Page DL. Expession of mitosis per thousand celi and celi density inbreast carcinomas. Hum Pathol 1992, 23 608-1 I.
32. Lipponen PK. Eskelinen MJ, Jauhiarnen K. Grading of superficial bladder cancer by quantıtatıve mitotic freuquency analysis. J Urol 1993; 149:36-41.
33. Donhuijsen K, Schimidt U. Hirehe H. Changes in mitotic rate and celi eyele fraetions caused by delayed fixation. HumPathol 1990;21:709-14.
34. Hail PA Levison DA. Revievv: Assessment of celi prolifera¬tion in histological material. J. Clin Pathol 1990;43:!84-92.
35. Oınn CM, Wrighy NA Revievv article. The clinical assess¬ment of proliferation and grovvth in human tumours: Evaluation of methods and applications as prognostic variables. J Pathol 1990;160:93-102.
36. Avunduk MC, Tekin Ş, Tavlı Ş. Memenin infiltratif duktal karsinomlannda P53. östrojen reseptör proteini. PCNA ve Kİ-67 ekspresyonu ile AgNOR indeksi özelliklerinin araştırılması. S. Ü. Tıp Fak Derg 1999;15:53-7.
37. Lipponen PK, Eskelinen MJ, Nordling S. Relationship betvveen DNA flow eytometric data, nuclear morfometric variables and volume-corrected mitotic index m transitio¬nal celi bladder tumors. Eur Urol 1991; 19:327-3 I.
38. Lipponen PK., Eskelinen MJ. and Sotarauta M. Prediction of superficial bladder cancer by histoquantitative met¬hods. Eur J Cancer 1990;26:1060-3.
Thank you for copying data from http://www.arastirmax.com